Cel-Sci (CVM) - Total debt

#9766

Rank

£38.69 M

Marketcap

🇺🇸 United States

Country

£4.84

Share price

2.54%

Change (1 day)

-58.86%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech

Cel-Sci - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year	Total debt	Change
2024-09-30	£8.68 M	-21.92%
2023-09-30	£11.12 M	-19.09%
2022-09-30	£13.75 M	15.98%
2021-09-30	£11.85 M	9.9%
2020-09-30	£10.78 M	-1.83%
2019-09-30	£10.99 M	7.11%
2018-09-30	£10.26 M	-3.23%
2017-09-30	£10.6 M	5.64%
2016-09-30	£10.03 M	9.32%
2015-09-30	£9.18 M	1227.41%
2014-09-30	£0.69 M	-1.19%
2013-09-30	£0.7 M	2.25%
2012-09-30	£0.68 M	-78.61%
2011-09-30	£3.2 M	355.65%
2010-09-30	£0.7 M	0.88%
2009-09-30	£0.69 M	516.25%
2008-09-30	£0.11 M
2005-09-30	£0 M	2.14%
2004-09-30	£0 M	-99.68%
2003-09-30	£0.52 M	-53.93%
2002-09-30	£1.13 M	5262.83%
2001-09-30	£0.02 M	25.45%
2000-09-30	£0.01 M

Total debt for similar companies or competitors

Company	Total debt/th>	differencediff.	Country
Curis CRIS	£1.47 M	-80.25%	🇺🇸 USA
BioCryst Pharmaceuticals BCRX	£0.48 B	6,377.60%	🇺🇸 USA
Amgen AMGN	£40.96 B	547,746.63%	🇺🇸 USA
Xencor XNCR	£51.98 M	595.18%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	£12.81 B	171,248.22%	🇮🇱 Israel
Johnson & Johnson JNJ	£34.36 B	459,508.27%	🇺🇸 USA
Emergent BioSolutions EBS	£0.49 B	6,555.01%	🇺🇸 USA
Eterna Therapeutics ERNA	£0.41 M	-94.46%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions